Title : Comparative effectiveness and safety study of triple therapy with simeprevir or telaprevir for non-cirrhotic patients with chronic hepatitis C virus genotype 1b infection.

Pub. Date : 2015 Dec

PMID : 26095167






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 CONCLUSIONS: Considering the effectiveness and safety, simeprevir-based triple therapy will continue to be a useful treatment option in Japan for treatment-naive or prior relapse patients with a favorable IL28B genotype. Simeprevir interferon lambda 3 Homo sapiens